Biomarkers of Clinical Subtype and Treatment Response in Obsessive-Compulsive Disorder
Conditions
Diseases of the Nervous System | Mental Health & Behavioral Research
Phase COVID-NA
Volunteers
Health Professionals
What is the purpose of this trial?
This study is meant to explore the neurobiological and psychological underpinnings of obsessive compulsive disorder (OCD). It consists of several parts, including a phone screen followed by some extensive interviews with staff. Research participation may then be offered in decision making tasks or different magnetic resonance (MR) scans. The volunteers being sought must be English speaking people, ages 18 to 70 years old, able to provide informed consent, in one of the following groups: without OCD (controls), with subclinical OCD symptoms (e.g. Contamination concerns) but no diagnosis, with diagnosable OCD. Economic reimbursement averages $20 per hour. Study participation requires several visits.
Interested individuals should call 203-974-7523 or toll free 1-855-OCD-YALE (1-855-623-9253).
or email: ocd.research@yale.edu
To learn more, please see our website: ocd.yale.edu
- Ages18 years - 70 years
- GenderBoth
- Trial withYale University School of Medicine
- Start Date05/06/2008
- End Date04/19/2025
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
Sub-Investigators
- Alan Anticevic, PhD
- Benjamin Kelmendi, MD
- Chiang-Shan Ray Li, MD, PhD
- Gerard Sanacora, PhD, MD
- Graeme Mason, PhD
- Ifat Levy, PhD
- Irina Esterlis, PhD
- John Krystal, MD
- John D Murray, PhD
- Lihong Jiang, PhD
- Linda Mayes, MD
- Martina Krenzer, MD
- Michael Bloch, MD, MS
- Michael Crowley, PhD
- Michelle Hampson, PhD
- Nicole Santamauro, MA
- Patrick Skosnik, PhD
- Thomas Fernandez, MD
- Youngsun Cho, MD/PhD
- Last Updated07/15/2021
- Study HIC#0803003626